Investigational Site Number: 3920002

Mibu 321-0293

0 studies enrolling now · 1 studies all time

What they study most

Dermatitis Atopic

Studies at this site

• A Study to Investigate the Efficacy and Safety of Subcutaneous Lunsekimig (SAR443765) Compared With Placebo in Adult Participants With Moderate-to-severe Atopic Dermatitis — Completed